Clinical safety of ibuprofen in pediatric practice

Authors

DOI:

https://doi.org/10.22141/2224-0551.16.6.2021.241719

Keywords:

antipyretic drug, analgesic effect, anti-inflammatory action, ibuprofen, children, pediatric practice, review

Abstract

The article presents a review of the literature on the side effects of ibuprofen in children. The international guidelines recommend ibuprofen as an antipyretic and analgesic drug in pediatrics. The drug is characterized by a high profile of efficacy and safety in the treatment of children with fever, mild to moderate pain. Ibuprofen in over-the-counter doses has a low probability of serious side effects from the gastrointestinal tract and kidneys. Side effects of ibuprofen are transient and resolve after discontinuation of treatment. Circumstances associated with a higher risk of adverse events are highlighted. The use of ibuprofen is contraindicated in children with dehydration, which is associated with a risk of acute kidney damage. Caution should be exercised when prescribing ibuprofen to children with community-acquired pneumonia due to the risk of purulent complications. Ibuprofen should not be prescribed to patients with chickenpox to avoid bacterial superinfections. Ibuprofen should be used with caution in children with diseases of the gastrointestinal tract, liver, renal failure, hemorrhagic syndrome, anticoagulant therapy. Ibuprofen is allowed in children with bronchial asthma unless a personal or family history of aspirin-induced asthma. Caution should be exercised when treating premature infants or low birth weight infants due to the reduction in nephron mass and, therefore, the increased risk of renal damage. Ibuprofen should not be used in patients who are sensitive to this drug or other non-steroidal anti-inflammatory drugs. Ibuprofen should be taken in the minimum effective dose and discontinued as soon as possible — no more than 3 days for fever and 5 days for pain.

Downloads

Download data is not yet available.

References

Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009 Dec;17(6):275-342. doi: 10.1007/s10787-009-0016-x.

Rainsford KD. Ibuprofen: from invention to an OTC therapeutic mainstay. Int J Clin Pract Suppl. 2013 Jan;(178):9-20. doi: 10.1111/ijcp.12055.

Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009 Sep;25(9):2207-22. doi: 10.1185/03007990903116255.

Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010 Mar;44(3):489-506. doi: 10.1345/aph.1M332.

Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. 2004 Jun;158(6):521-6. doi: 10.1001/archpedi.158.6.521.

Ziesenitz VC, Zutter A, Erb TO, van den Anker JN. Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months. Paediatr Drugs. 2017 Aug;19(4):277-290. doi: 10.1007/s40272-017-0235-3.

Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr Drugs. 2001;3(11):817-58. doi: 10.2165/00128072-200103110-00004.

Autret-Leca E, Bensouda-Grimaldi L, Maurage C, Jonville-Bera AP. Upper gastrointestinal complications associated with NSAIDs in children. Therapie. 2007 Mar-Apr;62(2):173-6. doi: 10.2515/therapie:2007032.

Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020 Dec;58(12):1360-1541. doi: 10.1080/15563650.2020.1834219.

de Martino M, Chiarugi A, Boner A, Montini G, De' Angelis GL. Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal. Drugs. 2017 Aug;77(12):1295-1311. doi: 10.1007/s40265-017-0751-z.

NICE Guideline Updates Team (UK). Fever in under 5s: assessment and initial management. London: National Institute for Health and Care Excellence (UK); 2019. Available from: https://www.nice.org.uk/guidance/ng143 .

Chiappini E, Venturini E, Remaschi G, et al; Italian Pediatric Society Panel for the Management of Fever in Children. 2016 Update of the Italian Pediatric Society Guidelines for Management of Fever in Children. J Pediatr. 2017 Jan;180:177-183.e1. doi: 10.1016/j.jpeds.2016.09.043.

Green C, Krafft H, Guyatt G, Martin D. Symptomatic fever management in children: A systematic review of national and international guidelines. PLoS One. 2021 Jun 17;16(6):e0245815. doi: 10.1371/journal.pone.0245815.

Hay AD, Costelloe C, Redmond NM, et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008 Sep 2;337:a1302. doi: 10.1136/bmj.a1302.

Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):398-405. doi: 10.1002/pds.1191.

van den Anker JN. Optimising the management of fever and pain in children. Int J Clin Pract Suppl. 2013 Jan;(178):26-32. doi: 10.1111/ijcp.12056.

Purssell E. Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone. Arch Dis Child. 2011 Dec;96(12):1175-9. doi: 10.1136/archdischild-2011-300424.

Pereira GL, Dagostini JM, Pizzol Tda S. Alternating antipyretics in the treatment of fever in children: a systematic review of randomized clinical trials. J Pediatr (Rio J). 2012 Jul;88(4):289-96. doi: 10.2223/JPED.2204.

Trippella G, Ciarcià M, de Martino M, Chiappini E. Prescribing Controversies: An Updated Review and Meta-Analysis on Combined/Alternating Use of Ibuprofen and Paracetamol in Febrile Children. Front Pediatr. 2019 Jun 5;7:217. doi: 10.3389/fped.2019.00217.

Wright AD, Liebelt EL. Alternating antipyretics for fever reduction in children: an unfounded practice passed down to parents from pediatricians. Clin Pediatr (Phila). 2007 Mar;46(2):146-50. doi: 10.1177/0009922806293922.

Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care. 2000 Dec;16(6):394-7. doi: 10.1097/00006565-200012000-00003.

Mullan J, Burns P, Weston K, Crowther S, Dixon R, Moselen E. What do Australian & New Zealand caregivers know about children's ibuprofen? The results of an online survey? BMC Pediatr. 2018 Oct 15;18(1):327. doi: 10.1186/s12887-018-1297-2.

Jin J, Wang X, Wang J, Wan Z. Efficacy and safety of ibuprofen in children with musculoskeletal injuries: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021 Jul 2;100(26):e26516. doi: 10.1097/MD.0000000000026516.

Parri N, Lazzeri S. Efficacy of ibuprofen in musculoskeletal post-traumatic pain in children: A systematic review. PLoS One. 2020 Dec 3;15(12):e0243314. doi: 10.1371/journal.pone.0243314.

Henretig FM, author; Jennifer A Sample JA, Wiley JF, editors. Ibuprofen poisoning in children and adolescents. Up To Date. 2021. Available from: https://www.uptodate.com/contents/ibuprofen-poisoning-in-children-and-adolescents

Brain P, Leyva R, Doyle G, Kellstein D. Onset of analgesia and efficacy of ibuprofen sodium in postsurgical dental pain: a randomized, placebo-controlled study versus standard ibuprofen. Clin J Pain. 2015 May;31(5):444-50. doi: 10.1097/AJP.0000000000000142.

Adebayo D, Bjarnason I. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J. 2006 Mar;82(965):186-91. doi: 10.1136/pgmj.2005.039586.

Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821-47. doi: 10.18433/j3vw2f.

Bianciotto M, Chiappini E, Raffaldi I, et al; Italian Multicenter Study Group for Drug and Vaccine Safety in Children. Drug use and upper gastrointestinal complications in children: a case-control study. Arch Dis Child. 2013 Mar;98(3):218-21. doi: 10.1136/archdischild-2012-302100.

Grimaldi-Bensouda L, Abenhaim L, Michaud L, et al. Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study. Eur J Clin Pharmacol. 2010 Aug;66(8):831-7. doi: 10.1007/s00228-010-0832-3.

Cardile S, Martinelli M, Barabino A, et al. Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children. World J Gastroenterol. 2016 Feb 7;22(5):1877-83. doi: 10.3748/wjg.v22.i5.1877.

Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract Suppl. 2003 Apr;(135):9-12.

Usta M, Urganci N. Upper Gastrointestinal Bleeding in Children: The Role of Helicobacter pylori Infection and Non-steroidal Anti-inflammatory Drug Use. West Indian Med J. 2015 Mar;64(2):113-6. doi: 10.7727/wimj.2014.130.

Lanas A, Ferrandez A. NSAIDs and the colon. Curr Opin Gastroenterol. 2009 Jan;25(1):44-9. doi: 10.1097/MOG.0b013e3283157c4d.

Ulinski T, Guigonis V, Dunan O, Bensman A. Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr. 2004 Mar;163(3):148-50. doi: 10.1007/s00431-003-1392-7.

Wong W, Coward RJ, Morris MC. Ibuprofen induced acute renal failure in an infant. N Z Med J. 2001 Sep 28;114(1140):431.

Leroy S, Mosca A, Landre-Peigne C, Cosson MA, Pons G. Quel niveau de preuve de l'efficacité et de la sécurité de l'ibuprofène dans ses indications pédiatriques? [Ibuprofen in childhood: evidence-based review of efficacy and safety]. Arch Pediatr. 2007 May;14(5):477-84. French. doi: 10.1016/j.arcped.2007.01.012.

Borysova TP, Obolonska OU. Influence of ibuprofen in closure of hemodynamically significant patent ductus arteriosus on the development of acute kidney injury in premature infants. Medicni perspektivi. 2021;26(1):156-162. doi: 10.26641/2307-0404.2021.1.227960.

Misurac JM, Knoderer CA, Leiser JD, Nailescu C, Wilson AC, Andreoli SP. Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr. 2013 Jun;162(6):1153-9, 1159.e1. doi: 10.1016/j.jpeds.2012.11.069.

Balestracci A, Ezquer M, Elmo ME, et al. Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis. Pediatr Nephrol. 2015 Oct;30(10):1873-8. doi: 10.1007/s00467-015-3105-7.

Carmody JB, Charlton JR. Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics. 2013 Jun;131(6):1168-79. doi: 10.1542/peds.2013-0009.

Gui MZ, Ni M, Yin XD, Zhang T, Li ZL. Ibuprofen induced Stevens-Johnson syndrome and liver injury in children: a case report. Transl Pediatr. 2021 Jun;10(6):1737-1742. doi: 10.21037/tp-21-8.

Argentieri J, Morrone K, Pollack Y. Acetaminophen and Ibuprofen overdosage. Pediatr Rev. 2012 Apr;33(4):188-9. doi: 10.1542/pir.33-4-188.

Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008 Feb;65(2):203-9. doi: 10.1111/j.1365-2125.2007.02997.x.

Durand L, Sachs P, Lemaitre C, et al. NSAIDs in paediatrics: caution with varicella! Int J Clin Pharm. 2015 Dec;37(6):975-7. doi: 10.1007/s11096-015-0184-2.

Dubos F, Hue V, Grandbastien B, Catteau B, Martinot A. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol. 2008;88(1):26-30. doi: 10.2340/00015555-0333.

Stone K, Tackley E, Weir S. BET 2: NSAIs and chickenpox. Emerg Med J. 2018 Jan;35(1):66-68. doi: 10.1136/emermed-2017-207366.2.

Quaglietta L, Martinelli M, Staiano A. Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic. Ital J Pediatr. 2021 Jan 29;47(1):20. doi: 10.1186/s13052-021-00974-0.

François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010 Jun;99(6):861-6. doi: 10.1111/j.1651-2227.2010.01734.x.

Elemraid MA, Thomas MF, Blain AP, et al; North East of England Pediatric Respiratory Infection Study Group Newcastle upon Tyne, UK. Risk factors for the development of pleural empyema in children. Pediatr Pulmonol. 2015 Jul;50(7):721-6. doi: 10.1002/ppul.23041.

Meganatham M, Awasthi S. Predicting Complicated Parapneumonic Effusion in Community Acquired Pneumonia: Hospital Based Case-Control Study. Indian J Pediatr. 2019 Feb;86(2):140-147. doi: 10.1007/s12098-018-2769-y.

Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. 2018 Jan;12(1):253-261. doi: 10.1111/crj.12524.

Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review. Adv Ther. 2020 Jan;37(1):61-82. doi: 10.1007/s12325-019-01144-9.

Su YM, Huang CS, Wan KS. Short-term ibuprofen treatment and pulmonary function in children with asthma. Indian Pediatr. 2015 Aug;52(8):691-3. doi: 10.1007/s13312-015-0698-7.

Debley JS, Carter ER, Gibson RL, Rosenfeld M, Redding GJ. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J Pediatr. 2005 Aug;147(2):233-8. doi: 10.1016/j.jpeds.2005.03.055.

Kader A, Hildebrandt T, Powell C. How safe is ibuprofen in febrile asthmatic children? Arch Dis Child. 2004 Sep;89(9):885-6. doi: 10.1136/adc.2004.057877.

Body R, Potier K. Best evidence topic report. Non-steroidal anti-inflammatory drugs and exacerbations of asthma in children. Emerg Med J. 2004 Nov;21(6):713-4. doi: 10.1136/emj.2004.019687.

Kauffman RE, Lieh-Lai M. Ibuprofen and increased morbidity in children with asthma: fact or fiction? Paediatr Drugs. 2004;6(5):267-72. doi: 10.2165/00148581-200406050-00001.

Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther. 2007 Dec;29(12):2716-23. doi: 10.1016/j.clinthera.2007.12.021. 

Martinelli M, Quaglietta L, Banderali G, Ferrara P, Romano C, Staiano A. Prescribing patterns, indications and adverse events of ibuprofen in children: results from a national survey among Italian pediatricians. Ital J Pediatr. 2021 Apr 21;47(1):98. doi: 10.1186/s13052-021-01047-y.

Taylor N. France’s ANSM warns about NSAIDs following safety review. Regulatory Affairs Profession- als. EU Regulatory Roundup Web site. 2019. Available from: https://www.raps.org/news-and-articles/news-articles/2019/4/eu-regulatoryroundup-frances-ansm-warns-about-n . Accessed: 4 Jun 2019.

Published

2022-01-05

How to Cite

Borysova, T. (2022). Clinical safety of ibuprofen in pediatric practice. CHILD`S HEALTH, 16(6), 418–424. https://doi.org/10.22141/2224-0551.16.6.2021.241719

Issue

Section

Review of Literature

Most read articles by the same author(s)

1 2 3 4 > >>